Articles written for the GLP list the source as Genes and Science. All other articles were written for the sources noted with excerpts provided by the GLP.

Another COVID-19 casualty: ‘Major delays’ for gene therapy trials for rare diseases

Larry Luxner&nbsp|&nbsp
While the ongoing COVID-19 pandemic won’t have much of an impact on cash available for new biotech startups, it has ...